Outcomes of Transperitoneal Laparoscopic Nephrectomy for Renal Adenocarcinoma

Česká verzia

Authors: L. Šafařík; K. Novák; M. Babjuk; M. Pešl; P. Macek; J. Dvořáček
Authors place of work: Urologická klinika 1. LF UK Praha, přednosta: prof. MUDr. J. Dvořáček
Published in the journal: Rozhl. Chir., 2008, roč. 87, č. 11, s. 601-604.
Category: Monothematic special - Original

Summary

Laparoscopic radical nephrectomy (LRN) is method of choice in malignant renal tumors (RCC) stage T1-3. Procedure has proved to be technically safe with low post-operative morbidity and standard oncological results, provided the patients are secondaries free in the time of surgery, and there was no positive margin in resected tissue. There was no recurrence even after 6 years of follow-up. The most influential variables regarding the survival of patients postoperatively were: presence of metastases in the time of surgery p < 0.0001, pathological grade p < 0.001, stage p < 0.018 and p < 0.046, respectively, if the tumors were 4 cm and bigger. It could be concluded, that laparoscopic way of removing the tumor with the kidney has proved the same oncological results even in the mid-term follow-up, if compared with classical open surgery done lege artis.

Key words:
laparoscopy – renal tumors – survival

Zdroje

1. European Association of Urology. Guidelines. 2008 Edition, Guidelines on Renal Cell Carcinoma.

2. Lindblad, P. Epidemiology of renal carcinoma. Scan. J. Surg., 2004; 93(2): 88–96.

3. Pischon, T., Lahmann, P. H., Boeing, H., et al. Body size and risk of renal cell carcinoma in the European prospective investigation into Cancer and Nutrition (EPIC). Int. J. Cancer, 2006; 118(3): 728–738.

4. Gong, E. M., Lyon M. B., Orvieto, M. A., et al. Laparoscopic radical nephrectomy: comparison of clinical stage T1 and T2 renal tumors. Urology, 2006; 68(6), 1183–1187.

5. Cadeddu, J. A., Ono, Y., Clayman, R. V., et al. Laparoscopic nephrectomy for renal cancer: evaluation of efficacy and safety – a multicenter experience. Urology, 1998; 52: 773–777.

6. Hasson, H. M. Open laparoscopy. Biomed. Bull., 1984, 5(1), 1–6.

7. Ponsky, L., Cherullo, E., Moinzadeh, A., et al. The Hem-o-lok clip is safe for laparoscopic nephrectomy: a multi-institutional review. Urology, 2008; 71(4): 593–596.

8. Feder, M. T., Patel M. B., Melman, A., et al. Comparison of open and laparoscopic nephrectomy in obese and nonobese patients: outcomes stratified by body mass index. J. Urol., 2008; 80(1): 79–83.

9. Msezane, L. P., Katz, M. H., Gofrit, O. N., et al. Hemostatic agents and instruments in laparoscopic renal surgery. J. Endourol., 2008; 22(3): 403–408.

10. Berger, A. D., Kanofsky, J. A., O‘Malley, R. L., et al. Transperitoneal laparoscopic radical nephrectomy for large (more than 7 cm) renal masses. Urology, 2008; 71(3): 421–424.

11. Hage, J. J. On the origin and evolution of the Roeder knot and loop-a geometrical review. Surg. Laparosc. Endosc. Percutan Tech., 2008; 18(1): 1–7. Review.

12. Flanigan, R. C., Mickisch, G., Sylvester, R., et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J. Urol., 2004; 171(3): 1071–1076.

13. Zubac, D. P., Bostad, L., Gestblom, C., et al. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy. Scand. J. Urol. Nephrol., 2007; 41(3): 191–197.

14. Hidas, G., Kastin, A., Mullerad, M., et al. Sutureless nephron-sparing surgery: use of albumin glutaraldehyde tissue adhesive (BioGlue). Urology, 2006; 67(4): 697–700.

15. Ficcara, V., Galfano, A., Guillé, F., et al. A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients. J. Urol., 2007 Aug; 178(2): 418–424; discussion 423–424.

16. Ito, K., Mizuguchi, Y., Sato, A., et al. Clinical evaluation for adrenal metastasis of renal cell carcinoma in a single institute. Nippon Hinyokika Gakkai Zasshi., 2008; 99(4): 584–592.

17. Breda, A., Konijeti, R., Lam, J. S. Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection. Expert Rev. Anticancer Ther., 2007; 7(6): 847–862.